Editorial Tag: ovarian
Hope For Newly Diagnosed Ovarian Cancer Patients – PARP Inhibitors Now FDA-Approved For Front-Line Ovarian Cancer Treatment
Two Major New Ovarian Cancer Approvals — Expanding Access To PARP Inhibitors
Chemotherapy: A Powerful Weapon Against Ovarian Cancer
Ovarian Cancer Surgery: What to Expect
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Ovarian Cancer: Genetic Testing
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Clinical Study of WT2725 in Patients With Advanced Malignancies
Is There Screening for Ovarian Cancer?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.